Vaxinano
Lille
About Vaxinano
Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human and veterinary vaccines and drug delivery systems. Vaxinano was created in 2016, building on 25 years of research and clinical trials on vaccines and the patented technology of Pr Didier Betbeder.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.5M
- Last round: Series Unknown (Oct 2024)
- Website: vaxinano.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Clinical Trials, Delivery, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/vaxinano-113065 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.